Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Porter

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Cancer|December 29, 2025
Frequency and face validity of reported family history of cancer in first-degree relatives and genetic syndromes among children with cancer in Project:EveryChild: A report from the Children's Oncology GroupNoemi A Fuentes Bolanos, Philip J Lupo, Katherine M Tucker, et al.
Molecular Cancer Therapeutics|October 15, 2013
Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionalityAnnemie A Van Linden, Dmitry Baturin, James B Ford, et al.
Biomacromolecules|February 6, 2023
Multicolor Light-Induced Immune Activation via Polymer Photocaged CytokinesLacey A Birnbaum, Emily C Sullivan, Priscilla Do, et al.
Advanced Healthcare Materials|March 10, 2021
Engineered Cytokines for Cancer and Autoimmune Disease ImmunotherapyBiaggio Uricoli, Lacey A Birnbaum, Priscilla Do, et al.
Molecular Cancer Therapeutics|June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute LeukemiaTamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Pediatric Blood & Cancer|July 6, 2023
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromesSantiago J Arconada Alvarez, Bojana Pencheva, Eleanor Westfall, et al.
Molecular Cancer Research : MCR|January 22, 2017
A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL ResistanceLina Y Dimberg, Christina G Towers, Kian Behbakht, et al.
American Journal of Hematology|June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemiaLori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Cell Reports|August 1, 2025
Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMMLHong Zheng, Peng Zhao, Zhenya Tan, et al.
Biomacromolecules|May 7, 2020
Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced LatencyLacey A Perdue, Priscilla Do, Camille David, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Cancer|December 29, 2025
Frequency and face validity of reported family history of cancer in first-degree relatives and genetic syndromes among children with cancer in Project:EveryChild: A report from the Children's Oncology GroupNoemi A Fuentes Bolanos, Philip J Lupo, Katherine M Tucker, et al.
Molecular Cancer Therapeutics|October 15, 2013
Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionalityAnnemie A Van Linden, Dmitry Baturin, James B Ford, et al.
Biomacromolecules|February 6, 2023
Multicolor Light-Induced Immune Activation via Polymer Photocaged CytokinesLacey A Birnbaum, Emily C Sullivan, Priscilla Do, et al.
Advanced Healthcare Materials|March 10, 2021
Engineered Cytokines for Cancer and Autoimmune Disease ImmunotherapyBiaggio Uricoli, Lacey A Birnbaum, Priscilla Do, et al.
Molecular Cancer Therapeutics|June 29, 2017
A Small-Molecule Inhibitor of WEE1, AZD1775, Synergizes with Olaparib by Impairing Homologous Recombination and Enhancing DNA Damage and Apoptosis in Acute LeukemiaTamara B Garcia, Jonathan C Snedeker, Dmitry Baturin, et al.
Pediatric Blood & Cancer|July 6, 2023
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromesSantiago J Arconada Alvarez, Bojana Pencheva, Eleanor Westfall, et al.
Molecular Cancer Research : MCR|January 22, 2017
A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL ResistanceLina Y Dimberg, Christina G Towers, Kian Behbakht, et al.
American Journal of Hematology|June 4, 2014
Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemiaLori A Gardner, Jelena Klawitter, Mark A Gregory, et al.
Cell Reports|August 1, 2025
Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMMLHong Zheng, Peng Zhao, Zhenya Tan, et al.
Biomacromolecules|May 7, 2020
Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced LatencyLacey A Perdue, Priscilla Do, Camille David, et al.
Pageof 8